In this model, there are both moderate impairment in insulin secretion and insulin resistance, which is a characteristic feature of T2DM (Ali et al., 2020; Gorinstein et al., 2007; Singh & Singh, 2010; Zhou et al., 2009). The gene discussed is INS; the disease is type 2 diabetes mellitus.